Meta AnalysisID 422

可可对代谢综合征结局的影响:系统评价与Meta分析

CRD42023388210

What is the effect of cocoa consumption on metabolic syndrome outcomes?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Herb: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
422
Evidence Id
8980
Core Evidence Id
8980
Source Meta Analysis Id
400
Herb2 Meta Analysis Id
HBMA000400
Crd Id
CRD42023388210
Title
Effect of Cocoa on Metabolic Syndrome Outcomes: A Systematic Review and Meta-Analysis
Review Question
What is the effect of cocoa consumption on metabolic syndrome outcomes?
Study Type Included
We will include randomised-controlled trials (both parallel and cross-over study design) to measure the effect of cocoa on metabolic syndrome outcomes.
Condition Being Studied
This review will focus on metabolic syndrome parameters as main outcomes. The outcomes are: 1) Blood glucose 2) Systolic blood pressure (SBP) 3) Diastolic blood pressure (DBP) 4) LDL-c levels 5) HDL-c levels
Participant
This study will involve free-living men and women (aged from 18 to 75 years) with metabolic syndrome defined as having three or more of the following conditions: 1) waist circumference over 40 inches (men) or 35 inches (women) 2) blood pressure over 130/85 mmHg 3) fasting triglyceride (TG) level over 150 mg/dL 4) fasting high-density lipoprotein (HDL) cholesterol level less than 40 mg/dL (men) or 50 mg/dL (women) 5) fasting blood sugar over 100 mg/dL The inclusion criteria are who did not take any medications, vitamins, and/or supplements during the study period. The exclusion criteria are those with dietary restrictions or medical conditions other than metabolic syndrome and women who are pregnant, or lactating were excluded.
Animal
Human Disease Modelled
Intervention
This review will include the following interventions: 1) Cocoa 2) Cocoa powder 3) Low and high flavanols cocoa 4) Dark chocolate 5) Polyphenol-rich dark chocolate The intake of the product can be either in the form of liquid, semi-solid, and solid.
Comparator Control
The appropriate control/comparators(s) should be either one or a combination of the following: 1) containing artificial flavour mimicking test food 2) containing artificial colour mimicking test food 3) containing same energy content as test food 4) containing same food matrix as test food
Main Outcome
This review will measure the effect size (Cohen's d) between treatment versus control group of the following outcomes: 1) Blood glucose 2) Systolic blood pressure (SBP) 3) Diastolic blood pressure (DBP) 4) LDL-c levels 5) HDL-c levels Measures of effect An effect size of 0.2, 0.5 and 0.8 are considered as small, medium and large, respectively.
Outcome Measure
Additional Outcome
A change from baseline (before) and after treatment. Measures of effect The change in item 25 will be measured as percentage (%) change.
Study Method
Intervention, Meta-analysis, Systematic review
Keyword
Cacao; Chocolate; Food; Humans; Metabolic Syndrome; Physiological Phenomena
Contact
Sharvintha Salaish Kumar [email protected]
Organisational Affiliation
Universiti Sultan Zainal Abidin (UniSZA), Malaysia www.unisza.edu.my
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Malaysia
Review Stage
Review Ongoing
First Submission Date
2023-01-04
Registration Date
2023-01-15
Anticipated Start Date
2022-12-01
Anticipated Completion Date
2023-06-30
Title Cn
可可对代谢综合征结局的影响:系统评价与Meta分析
Title En
Effect of Cocoa on Metabolic Syndrome Outcomes: A Systematic Review and Meta-Analysis
Bilingual Status
complete